CMS Open Payments · Program Year 2024
Ferring Pharmaceuticals AS
Ferring Pharmaceuticals AS reported $1,839,721.13 in payments to 83 physicians and teaching hospitals across 361 transactions.
- $1.8M
- Total payments
- 361
- Transactions
- 83
- Recipients
- −$125.2K
- General Payments vs PY2023
Ferring Pharmaceuticals AS reported $1,839,721.13 in payments to 83 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #469 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $22.2K per recipient across 3 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
The verdict
Ferring Pharmaceuticals AS pairs top-quartile payment volume with a moderately concentrated payment pattern.
- #469
- of 1,925 companies
- 0.0%
- of all US industry payments
- 0.3%
- paid to its single top recipient
- 3
- payment categories
Release-over-release change
General Payments changed from PY2023 to PY2024
Ferring Pharmaceuticals AS's CMS-reported General Payments decreased by $125.2K (−63.6%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.
CMS source labels for this exact identifier: PY2022: FERRING PHARMACEUTICALS ASPY2023: FERRING PHARMACEUTICALS ASPY2024: Ferring Pharmaceuticals AS. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $196,707.91
- PY2024
- $71,511.71
How Ferring Pharmaceuticals AS ranks nationally
Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.
Ferring Pharmaceuticals AS's total vs. every reporting company
CMS Open Payments, Program Year 2024
$1,839,721 Top 24% higher than 76% of 1,925 reporting companies
Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Open Payments · 2024
What the Data Shows for Ferring Pharmaceuticals AS
$1,839,721.13: that is what Ferring Pharmaceuticals AS reported in payments to 83 physicians and teaching hospitals during Program Year 2024, spread across 361 transactions ($5.1K per transaction, $22.2K per recipient). The company sits at rank #469 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
"Consulting Fee" leads the 3-category general-payment breakdown below at $48.3K (2.6% of the company's reported total, 10 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Ferring Pharmaceuticals AS made 3 types of general payments. "Consulting Fee" is the largest category at $48.3K, 2.6% of the company's reported total.
How Ferring Pharmaceuticals AS divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $48.3K | 10 | 2.6% |
| Travel and Lodging | $19.1K | 42 | 1.0% |
| Food and Beverage | $4.1K | 31 | 0.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $47,050.27 (65.8%) of $71,511.71 in this company's General Payments records across 24 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Ferring Pharmaceuticals AS
The five named recipients with the highest reported General Payments from this company
- 1
Eve Feinberg
$22,829.79 across 2 reported transactions
- 2
Fady Sharara
$11,988.48 across 3 reported transactions
- 3
Sahil Khanna
$4,900.00 across 3 reported transactions
- 4
Daniel Dumesic
$4,860.00 across 1 reported transactions
- 5
Florian Rieder
$2,472.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Payment Size Analysis
Average transaction size: $5.1K. Average per recipient: $22.2K.
Total Amount
$1,839,721.13
Avg per Transaction
$5.1K
Avg per Recipient
$22.2K
Payment Transparency Context
What is the Sunshine Act?
The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.
Industry Total (2024)
$13.9B
across 1,925 companies
Ferring Pharmaceuticals AS Share
0.0%
#469 by total payments
Companies with Similar Payment Volumes
Pharmaceutical companies with payment totals similar to Ferring Pharmaceuticals AS
Frequently Asked Questions
How much did Ferring Pharmaceuticals AS pay to physicians and hospitals in 2024? ▾
How many physicians received payments from Ferring Pharmaceuticals AS? ▾
What types of payments did Ferring Pharmaceuticals AS make? ▾
How does Ferring Pharmaceuticals AS rank among pharmaceutical companies? ▾
What is the average payment size from Ferring Pharmaceuticals AS? ▾
Where does the payment data for Ferring Pharmaceuticals AS come from? ▾
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.